BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhat M, Jatyan R, Mittal A, Mahato RI, Chitkara D. Opportunities and challenges of fatty acid conjugated therapeutics. Chem Phys Lipids 2021;236:105053. [PMID: 33484709 DOI: 10.1016/j.chemphyslip.2021.105053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tibori K, Orosz G, Zámbó V, Szelényi P, Sarnyai F, Tamási V, Rónai Z, Mátyási J, Tóth B, Csala M, Kereszturi É. Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant. Int J Mol Sci 2022;23:6221. [PMID: 35682900 DOI: 10.3390/ijms23116221] [Reference Citation Analysis]
2 Xu MQ, Zhong T, Yao X, Li ZY, Li H, Wang JR, Feng ZH, Zhang X. Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles. Drug Deliv 2021;28:1603-15. [PMID: 34319209 DOI: 10.1080/10717544.2021.1958107] [Reference Citation Analysis]
3 Linciano S, Moro G, Zorzi A, Angelini A. Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions. J Control Release 2022;348:115-26. [PMID: 35643382 DOI: 10.1016/j.jconrel.2022.05.038] [Reference Citation Analysis]